Pacira BioSciences, Inc. (PCRX) revenue

Revenue · fiscal 2025
$726.41M

Pacira BioSciences, Inc. (PCRX) reported revenue of $726.41M in fiscal 2025 (the year ended December 31, 2025). That is 3.6% higher than the $700.97M of fiscal 2024. Figures as of 18 Nov 2026, 12:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$726.41M
Change on fiscal 2024
+3.6%
Growth, 5 years
+11.1% a year
Growth, 10 years
+11.3% a year
Highest on record
$726.41Mfiscal 2025
Lowest on record
$14.56Mfiscal 2010
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pacira BioSciences, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 11.1% a year; over ten years the rate was 11.3% a year. Across the 17 fiscal years on record (2009–2025), the highest was $726.41M in fiscal 2025 and the lowest $14.56M in fiscal 2010.

History · 17 fiscal years

Revenue by fiscal year

Pacira BioSciences, Inc. revenue, year by year

Pacira BioSciences, Inc. (PCRX) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$726.41M 3.6% up
2024$700.97M 3.9% up
2023$674.98M 1.2% up
2022$666.82M 23.1% up
2021$541.53M 26.0% up
2020$429.65M 2.6% up
2019$418.93M 26.0% up
2018$332.43M 16.9% up
2017$284.34M 5.3% up
2016$270.07M 8.5% up
2015$249.00M 26.0% up
2014$197.67M 131.1% up
2013$85.55M 118.9% up
2012$39.08M 149.1% up
2011$15.69M 7.7% up
2010$14.56M 3.0% down
2009$15.01M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on PCRX

Pacira BioSciences, Inc., figure by figure

Pacira BioSciences, Inc. (PCRX) overview: price, valuation and scorecard

Pacira BioSciences, Inc. revenue: questions and answers

What is Pacira BioSciences, Inc.'s revenue?

Pacira BioSciences, Inc. (PCRX) reported revenue of $726.41M in fiscal 2025 (the year ended December 31, 2025). That is 3.6% higher than the $700.97M of fiscal 2024.

What is the growth rate of Pacira BioSciences, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 11.1% a year; over ten years the rate was 11.3% a year.

What are the highest and lowest revenue figures on record for Pacira BioSciences, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $726.41M in fiscal 2025 and the lowest $14.56M in fiscal 2010.

How is Pacira BioSciences, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Pacira BioSciences, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pacira BioSciences, Inc. (PCRX) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/PCRX/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.